These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 7972349

  • 1. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

  • 2. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M, Attali P, Coquelin JP.
    Clin Ther; 1993 Jul; 15(1):127-36. PubMed ID: 8458042
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 5. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 6. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG.
    Clin Neuropharmacol; 2008 Oct; 31(1):40-50. PubMed ID: 18303490
    [Abstract] [Full Text] [Related]

  • 7. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 8. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 15; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 9. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC, van Balkom AJ, Zitman FG.
    Eur Neuropsychopharmacol; 2004 Aug 15; 14(4):301-6. PubMed ID: 15163440
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun 15; 251(3):117-23. PubMed ID: 11697572
    [Abstract] [Full Text] [Related]

  • 11. Minimal rebound insomnia after treatment with 10-mg zolpidem.
    Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW.
    Clin Neuropharmacol; 1997 Apr 15; 20(2):116-25. PubMed ID: 9099463
    [Abstract] [Full Text] [Related]

  • 12. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M, Yagi T, Itoh H, Tamura Y, Inoue Y, Uchimura N, Sasaki M, Shimizu T, Terzano MG, Parrino L.
    Pharmacopsychiatry; 2008 May 15; 41(3):106-14. PubMed ID: 18484552
    [Abstract] [Full Text] [Related]

  • 13. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B, Anderer P, Brandstätter N, Frey R, Grünberger J, Klösch G, Mandl M, Wetter T, Zeitlhofer J.
    Neuropsychobiology; 1994 May 15; 29(2):69-90. PubMed ID: 8170529
    [Abstract] [Full Text] [Related]

  • 14. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.
    Frattola L, Maggioni M, Cesana B, Priore P.
    Drugs Exp Clin Res; 1990 May 15; 16(7):371-6. PubMed ID: 2092963
    [Abstract] [Full Text] [Related]

  • 15. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB.
    J Clin Psychiatry; 1993 Jan 15; 54(1):33-8. PubMed ID: 8428895
    [Abstract] [Full Text] [Related]

  • 16. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL, Findling RL, Shih WJ, Soubrane C, Reed MD.
    Pediatrics; 2009 May 15; 123(5):e770-6. PubMed ID: 19403468
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.
    Morgan PJ, Chapados R, Chung FF, Gauthier M, Knox JW, Le Lorier J.
    J Clin Anesth; 1997 Mar 15; 9(2):97-102. PubMed ID: 9075032
    [Abstract] [Full Text] [Related]

  • 18. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 19. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM, Alvariño F, Monti D.
    Sleep; 2000 Dec 15; 23(8):1075-84. PubMed ID: 11145322
    [Abstract] [Full Text] [Related]

  • 20. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T.
    J Psychopharmacol; 2012 Aug 15; 26(8):1088-95. PubMed ID: 22004689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.